Company Filing History:
1 out of 1 
1 out of 1 
1 out of 30 Years Active: 2014-2017
Title: The Innovations of Evelyn Exner
Introduction
Evelyn Exner is a notable inventor based in Nuβloch, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, her work focuses on addressing health challenges associated with viral infections.
Latest Patents
Evelyn Exner's latest patents include an innovative anti-HSV antibody. This invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising an effective amount of the said antibody, an expression vector comprising a nucleotide sequence that encodes the said antibody, a host cell comprising the said nucleotide sequence, and a hybridoma cell capable of producing the said antibody. The use of this antibody as a drug is particularly aimed at the prophylactical or therapeutical treatment of HSV-associated diseases in a subject.
Career Highlights
Throughout her career, Evelyn Exner has worked with prominent organizations such as Heidelberg Immunotherapeutics GmbH and Universität Duisburg Essen. Her experience in these institutions has allowed her to advance her research and contribute to significant innovations in the field of immunotherapy.
Collaborations
Evelyn has collaborated with esteemed colleagues, including Michael Roggendorf and Anna-Maria Eis-Hübinger. These partnerships have fostered a collaborative environment that enhances the development of her innovative solutions.
Conclusion
Evelyn Exner's contributions to the field of biotechnology, particularly through her patents on anti-HSV antibodies, highlight her role as a leading inventor in the industry. Her work continues to pave the way for advancements in therapeutic treatments for viral infections.